We are live on ! Find out more
BBH icon

VanEck Biotech ETF

115 hedge funds and large institutions have $147M invested in VanEck Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 35 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $243K

0.2% more ownership

Funds ownership: 30.44%30.64% (+0.2%)

9% less funds holding

Funds holding: 126115 (-11)

14% less capital invested

Capital invested by funds: $171M → $147M (-$23.5M)

34% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 35

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

Holders
115
Holders Change
-11
Holders Change %
-8.73%
% of All Funds
1.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
23
Reduced
35
Closed
21
Calls
$1.02M
Puts
$243K
Net Calls
+$781K
Net Calls Change
+$2.1M
Name Holding Trade Value Shares
Change
Change in
Stake
IFWM
26
Institute for Wealth Management
Colorado
$1.27M -$13K -80 -1%
NFG
27
Norris Financial Group
South Carolina
$1.24M +$1.24M +7,675 New
Stifel Financial
28
Stifel Financial
Missouri
$1.21M +$113K +695 +10%
SBH
29
Segall Bryant & Hamill
Illinois
$1.04M +$1.03M +6,390 New
PSF
30
Pacific Sun Financial
California
$1.01M -$2.43K -15 -0.2%
Ameriprise
31
Ameriprise
Minnesota
$1M -$161K -993 -14%
ACA
32
Atlas Capital Advisors
Wyoming
$924K
GJIC
33
Gamble Jones Investment Counsel
California
$924K
Citadel Advisors
34
Citadel Advisors
Florida
$828K -$1.13M -6,948 -58%
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$810K -$7.45K -46 -0.9%
Cetera Investment Advisers
36
Cetera Investment Advisers
Illinois
$804K -$230K -1,418 -22%
SFPG
37
Stonebridge Financial Planning Group
Florida
$767K -$409K -2,526 -35%
AL
38
Aspiriant LLC
California
$765K -$31.1K -192 -4%
Wells Fargo
39
Wells Fargo
California
$703K -$660K -4,073 -48%
NWA
40
Navis Wealth Advisors
New York
$634K
IAMOG
41
Investors Asset Management of Georgia
Georgia
$600K
Truist Financial
42
Truist Financial
North Carolina
$556K -$27.9K -172 -5%
PWP
43
Pursue Wealth Partners
California
$550K +$534K +3,300 New
Osaic Holdings
44
Osaic Holdings
Arizona
$549K -$31.3K -193 -5%
BFC
45
Blue Fin Capital
Rhode Island
$530K +$530K +3,271 New
TC
46
Telemus Capital
Michigan
$511K +$810 +5 +0.2%
FNBOSM
47
First National Bank of South Miami
Florida
$464K -$18.6K -115 -4%
Northern Trust
48
Northern Trust
Illinois
$462K
WJWM
49
Williams Jones Wealth Management
New York
$431K -$87.5K -540 -17%
CM
50
Columbus Macro
Pennsylvania
$423K +$8.75K +54 +2%

BBH Hedge Fund Activity: Q1 2022 in Review

115 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2022, worth a combined $147M — down 14% from $171M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of BBH and 13 opened new positions — a net loss of 8 holders — while 35 trimmed existing stakes and 23 added.

The largest buyer was Traphagen Investment Advisors, adding an estimated $8.97M. The largest seller was Bank of America, cutting an estimated $9.88M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2022, down from 126 in Q4 2021.
  • Funds reported $147M of VanEck Biotech ETF stock for Q1 2022, down 14% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q1 2022 and 21 closed out, a net change of -8 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2022 was Traphagen Investment Advisors, an estimated $8.97M added.
  • The largest VanEck Biotech ETF seller in Q1 2022 was Bank of America, an estimated $9.88M sold.

Based on aggregated 13F filings for Q1 2022.